KKKiersten J. Kugeler

Kiersten J. Kugeler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years

Recognitions

Top Cited Scholar (2026)

Kiersten J. Kugeler has a total of 423 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Using Electronic Health Records to Enhance Lyme Disease Surveillance: Protocol for the SubLyme Network

    by Annemarie G Hirsch, Brian S Schwartz, Melissa N Poulsen, Anna M Schotthoefer, Maria E Sundaram, Jacob E Lemieux, Linden T Hu, Robert P Smith, Alexandra M Linz, Steph Battan-Wraith, et al.

    Background: Lyme disease is the most common vector-borne illness in the United States. The limitations of traditional surveillance strategies for Lyme disease affect the ability to reliably track its burden and evaluate interventions. The US Centers for Disease Control and Prevention (CDC) established the Surveillance Based Lyme Disease Network (SubLyme) in September 2023 to strengthen Lyme disease surveillance and research using electronic health record (EHR) data. Objective: SubLyme has three primary objectives: (1) to establish and evaluate criteria for identifying Lyme disease cases in EHR data (ie, create computable phenotypes [CPs]) that can be scaled across diverse health systems, (2) to estimate Lyme disease incidence, and (3) to describe Lyme disease incidence by key demographics. Secondary objectives are to develop CPs that distinguish between acute and disseminated Lyme disease, identify clinical manifestations, and support future research efforts. This paper describes SubLyme, its structure, and its methods. Methods: SubLyme includes 5 health systems in 3 US regions with a high risk of Lyme disease: Geisinger, in Pennsylvania; Marshfield Clinic Health System, in Wisconsin; and Mass General Brigham, Tufts Medical Center, and MaineHealth in New England. The network is administered by a coordinating center (Westat) and the US CDC. SubLyme is evaluating the validity of EHR-based CP definitions for Lyme disease. CP performance is assessed by measuring sensitivity, specificity, positive predictive value, and negative predictive value against manually abstracted medical charts. Each site identified a cohort of patients with any Lyme disease element in their EHR (Lyme disease diagnosis code, Lyme disease laboratory test order, and Lyme-appropriate antibiotic order) during 2022 to 2023 and selected 500 charts for manual review as the gold standard against which CP performance was evaluated. SubLyme will use the Lyme disease CPs to generate incidence rates for Lyme disease overall and for various subgroups. Results: SubLyme identified 332,256 patients with at least 1 Lyme disease element in their record from more than 4.6 million patients. Of these patients, 55.6% (n=184,734) were female, 87.9% (n=292,053) were White, and 90.8% (n=301,688) were non-Hispanic. More than half of the patients only had a Lyme-appropriate medication order (n=177,425, 53.4%) and 35.8% (n=118,948) only had a Lyme disease test order. The most common combination was a medication order with a laboratory test order (n=22,926, 6.9%), followed by a combination of a diagnosis, test, and medication order (n=5316, 1.6%). Conclusions: SubLyme is well positioned to advance Lyme disease surveillance using EHR data across multiple health systems. The exploration of new surveillance methods in Lyme disease is critical as disease frequency increases and the geography expands. An EHR-based approach to surveillance has the potential to overcome challenges of current surveillance strategies and to accelerate Lyme disease research. International Registered Report Identifier (IRRID): DERR1-10.2196/94921


  • Open Access

    Using Electronic Health Records to Enhance Lyme Disease Surveillance: Protocol for the SubLyme Network (Preprint)

    by Annemarie G Hirsch, Brian S Schwartz, Melissa N Poulsen, Anna M Schotthoefer, Maria E Sundaram, Jacob E Lemieux, Linden T Hu, Robert P Smith, Alexandra M Linz, Steph Battan-Wraith, et al.

    BACKGROUND Lyme disease is the most common vector-borne illness in the United States. The limitations of traditional surveillance strategies for Lyme disease affect the ability to reliably track its burden and evaluate interventions. The US Centers for Disease Control and Prevention (CDC) established the Surveillance Based Lyme Disease Network (SubLyme) in September 2023 to strengthen Lyme disease surveillance and research using electronic health record (EHR) data. OBJECTIVE SubLyme has three primary objectives: (1) to establish and evaluate criteria for identifying Lyme disease cases in EHR data (ie, create computable phenotypes [CPs]) that can be scaled across diverse health systems, (2) to estimate Lyme disease incidence, and (3) to describe Lyme disease incidence by key demographics. Secondary objectives are to develop CPs that distinguish between acute and disseminated Lyme disease, identify clinical manifestations, and support future research efforts. This paper describes SubLyme, its structure, and its methods. METHODS SubLyme includes 5 health systems in 3 US regions with a high risk of Lyme disease: Geisinger, in Pennsylvania; Marshfield Clinic Health System, in Wisconsin; and Mass General Brigham, Tufts Medical Center, and MaineHealth in New England. The network is administered by a coordinating center (Westat) and the US CDC. SubLyme is evaluating the validity of EHR-based CP definitions for Lyme disease. CP performance is assessed by measuring sensitivity, specificity, positive predictive value, and negative predictive value against manually abstracted medical charts. Each site identified a cohort of patients with any Lyme disease element in their EHR (Lyme disease diagnosis code, Lyme disease laboratory test order, and Lyme-appropriate antibiotic order) during 2022 to 2023 and selected 500 charts for manual review as the gold standard against which CP performance was evaluated. SubLyme will use the Lyme disease CPs to generate incidence rates for Lyme disease overall and for various subgroups. RESULTS SubLyme identified 332,256 patients with at least 1 Lyme disease element in their record from more than 4.6 million patients. Of these patients, 55.6% (n=184,734) were female, 87.9% (n=292,053) were White, and 90.8% (n=301,688) were non-Hispanic. More than half of the patients only had a Lyme-appropriate medication order (n=177,425, 53.4%) and 35.8% (n=118,948) only had a Lyme disease test order. The most common combination was a medication order with a laboratory test order (n=22,926, 6.9%), followed by a combination of a diagnosis, test, and medication order (n=5316, 1.6%). CONCLUSIONS SubLyme is well positioned to advance Lyme disease surveillance using EHR data across multiple health systems. The exploration of new surveillance methods in Lyme disease is critical as disease frequency increases and the geography expands. An EHR-based approach to surveillance has the potential to overcome challenges of current surveillance strategies and to accelerate Lyme disease research. INTERNATIONAL REGISTERED REPORT DERR1-10.2196/94921

  • Open Access

    Lyme Disease Testing Practices, Wisconsin, USA, 2016–2019

    by Kiersten J. Kugeler, Erica Scotty, Austin Earley, Alison F. Hinckley, Sarah A. Hook, Courtney C. Nawrocki, Alexandra M. Linz, Jennifer Meece, Anna M. Schotthoefer

    Lyme Disease Testing Patterns, USA


  • Revisiting the Relationship between Weather and Interannual Variation in Human Plague Cases in the Southwestern United States

    by Karen M. Holcomb, Brad J. Biggerstaff, Michael A. Johansson, Paul S. Mead, Kiersten J. Kugeler, Rebecca J. Eisen

    : Plague is a rare, potentially fatal flea-borne zoonosis endemic in the western United States. A previous model described interannual variation in human cases based on temperature and lagged precipitation. We recreated this model in northeastern Arizona (1960–1997) to evaluate its capacity to predict recent cases (1998–2022). In recreating the original model, we found that future instead of concurrent temperature had inadvertently been used for the presented fit. Prediction from our revised models with lagged precipitation and temporally plausible temperature relationships aligned with low observed cases in 1998–2022. Elevated precipitation associated with high cases in historical data (>6 inches combined precipitation over two previous springs) was only observed once in the last quarter century, so we could not assess if these conditions were reliably associated with elevated (four or more) human plague cases. Observed weather conditions were similar to those previously associated with low (fewer than or equal to two) case counts, suggesting “baseline” conditions in the last quarter century.


  • Epidemiology of Lyme Disease as Identified Through Electronic Health Records in a Large Midwestern Health System, 2016–2019

    by Kiersten J Kugeler, Erica Scotty, Alison F Hinckley, Sarah A Hook, Courtney C Nawrocki, Anne M Nikolai, Alexandra M Linz, Jennifer Meece, Anna M Schotthoefer

    Background: Lyme disease is the most common vector-borne disease in the United States; however, its frequency is not reliably measured through surveillance. Electronic health records (EHR) might capture the frequency and characteristics of Lyme disease cases more accurately. We queried EHR from 1 health system to describe the epidemiology of Lyme disease cases in Wisconsin during 2016–2019. Methods: Within a cohort of persons evaluated for Lyme disease, we applied a Lyme disease case definition based on first-line antibiotics within 14 days of a Lyme disease diagnosis code or test order or on the same day as a related keyword in clinical notes. We compared characteristics of cases to those of cases reported through surveillance and reviewed medical charts to assess case definition validity. Results: Among 67 289 possible Lyme disease events in the cohort, 13 494 (20.1%) met our Lyme disease case definition. Cases were more common among males, children 5–9 years, older adults, White non-Hispanic persons, and in the summer months. EHR-based Lyme disease incidence was 4–8 times that reported through surveillance. The EHR definition had moderately high sensitivity (83.4%) and specificity (71.1%) for confirmed and probable Lyme disease. Conclusions: EHR queries show promise to capture the incidence of Lyme disease more completely and provide more robust clinical information than public health surveillance. Demographic and seasonal characteristics of EHR-identified cases were comparable to those identified through surveillance. Further algorithm refinement might improve accuracy of measuring Lyme disease in EHR systems.


  • Top Cited Papers
    Open Access

    Tularemia — United States, 2011–2022

    by Shannan N. Rich, Alison F. Hinckley, Austin Earley, Jeannine M. Petersen, Paul S. Mead, Kiersten J. Kugeler

    This report describes an increase in Tularemia cases in 2011–2022 compared to 2001–2010.


  • Pregnancy Among Reported Lyme Disease Cases—United States, 1992–2019

    by Taylor D. Bostic, Kiersten J. Kugeler, Alison F. Hinckley

    Background: Lyme disease (LD), the most common vector‐borne disease in the United States, typically presents with a localised erythema migrans rash (EM). Left untreated, infection can disseminate to cause severe heart, joint or nervous system manifestations. Summaries of LD surveillance data have been published previously but did not include the frequency, demographic or clinical characteristics of LD cases during pregnancy.Methods: We summarised confirmed and probable LD cases by pregnancy status as reported to the U.S. Centers for Disease Control and Prevention during 1992–2019. We defined an LD case during pregnancy as one with (1) female sex, (2) age 14–49 years and (3) positive pregnancy indication. We evaluated the frequency, seasonality, age distribution, race and ethnicity, geographic distribution and clinical manifestations of LD cases during pregnancy and cases among non‐pregnant females. We compared proportions using chi‐squared tests.Results: Among 698,876 reported LD cases, 112,002 (16%) were confirmed or probable cases among females aged 14–49 years; 32,301 (29%) were specifically reported as non‐pregnant and 643 (0.6%) (568 confirmed and 75 probable cases) reported as pregnant. Illness onset peaked in June among LD cases during pregnancy, but in July for cases among non‐pregnant females. A higher proportion of confirmed LD cases during pregnancy had only EM rash than did cases among non‐pregnant females (66% vs. 60%, p = 0.019).Conclusions: LD cases during pregnancy are rare. Compared to non‐pregnant females, cases among pregnant females more commonly involve early clinical manifestations. These patterns could suggest earlier detection or more complete reporting of LD cases during pregnancy than their non‐pregnant counterparts. Earlier detection could be due to frequent contact with healthcare or increased self‐advocacy during pregnancy. Prompt antimicrobial treatment is critical for preventing severe disease and reducing risk of adverse pregnancy or birth outcomes.


  • Lyme Disease Surveillance and Epidemiology in the United States: A Historical Perspective

    by Paul Mead, Alison Hinckley, Kiersten Kugeler

    In the 40 years since Steere and colleagues first described Lyme disease, the illness has increased in incidence and distribution to become the most common vector-borne disease in the United States. Public health officials have developed, implemented, and revised surveillance systems to describe and monitor the condition. Much has been learned about the epidemiology of the illness, despite practical and logistical constraints that have encumbered the collection and interpretation of surveillance data. Future development of automated data collection from electronic health records as a source of surveillance and clinical information will address practical challenges and help answer ongoing questions about complications and persistent symptoms. Robust surveillance will be essential to monitor the effectiveness and safety of future vaccines and other preventive measures.


  • Epidemiologic and tick exposure characteristics among people with reported Lyme disease – Minnesota, 2011–2019

    by Austin R. Earley, Elizabeth K. Schiffman, Karen K. Wong, Alison F. Hinckley, Kiersten J. Kugeler

    Aims and Methods: In the United States, blacklegged Ixodes spp. ticks are the primary vector of Lyme disease. Minnesota is among the states with the highest reported incidence of Lyme disease, having an average of 1857 cases reported annually during 2011–2019. In contrast to the Northeast and mid‐Atlantic United States where exposure to ticks predominately occurs around the home, the circumstances regarding risk for exposure to blacklegged ticks in Minnesota are not well understood, and risk is thought to be highest in rural areas where people often participate in recreational activities (e.g. hiking, visiting cabins). We analysed enhanced surveillance data collected by the Minnesota Department of Health during 2011–2019 to describe epidemiologic and tick exposure characteristics among people with reported Lyme disease.Results: We found that younger age, male gender, residence in a county with lower Lyme disease risk, residence in the Minneapolis‐St. Paul metropolitan area, and an illness onset date later in the year were independently associated with higher odds of reporting tick exposures away from the home. We also describe the range of activities associated with tick exposure away from the home, including both recreational and occupational activities.Conclusions: These findings refine our understanding of Lyme disease risk in Minnesota and highlight the need for heterogeneous public health prevention messaging, including an increased focus on peridomestic prevention measures among older individuals living in high‐risk rural areas and recreational and occupational prevention measures among younger individuals living in the Minneapolis‐St. Paul metropolitan area.


  • Top Cited Papers
    Open Access

    Surveillance for Lyme Disease After Implementation of a Revised Case Definition — United States, 2022

    by Kiersten J. Kugeler, Austin Earley, Paul S. Mead, Alison F Hinckley

    This report describes the first year of Lyme disease surveillance data collected using the 2022 case definition compared to cases reported during 2017–2019.